This study is looking at ways to find glaucoma early in people who might be at higher risk. Glaucoma is an eye disease that can cause vision loss if not treated. The study will compare two approaches: one group will receive an educational brochure about glaucoma screening, and another group will be offered a glaucoma screening using special eye tests like optical coherence tomography (OCT), color fundus photography, and tonometry (which measures eye pressure). Researchers want to see if the screening tests lead to more people being diagnosed with glaucoma or being identified as needing treatment within three months. You may be able to join if you are Black and 50 or older, Hispanic and 65 or older, or have diabetes and are 50 or older, and have recently visited a Federally Qualified Health Center.

Study design

This is an interventional study planning to enroll 2000 participants. It is a randomized trial comparing glaucoma screening with education alone or delayed intervention.

What's involved

Participants will either receive an educational brochure by mail or be offered a screening appointment. The screening appointment includes visual acuity, OCT, color fundus photography, tonometry, and visual field testing.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome of glaucoma diagnosis or suspect requiring treatment will be measured at 3 months from randomization. Other benefits will be assessed one year after screening.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.